New Website Puts Under-Diagnosed Disease Affecting 1 in 133 Americans in the Spotlight

Gluten-Answers.com begins mission to educate millions on Celiac disease and provide them with information on how to cure the symptoms of the disease naturally.

Orlando, Florida (PRWEB) August 24, 2008 -- A new website begins its campaign to educate millions on a commonly under diagnosed autoimmune disease known as Celiac disease that afflicts 1 in 133 Americans. Researchers estimate that only 3% of sufferers are ever diagnosed by a physician.

Gluten-Answers.com (http://www.gluten-answers.com) not only educates visitors on the disease, but provides valuable information on how to properly screen and avoid foods that contain gluten (the protein that triggers severe symptoms in Celiacs) through videos, audio interviews with medical experts, research articles, and downloadable guides.

"It is hoped that through the education of physicians, nurses, dieticians, pharmacist, and the public, there will be an increased responsiveness to the signs and symptoms of the undiagnosed and untreated celiac patient," says Dr. Michelle Pietzak, M.D., Assistant Professor of Pediatrics at the Keck School of Medicine of the University of Southern California.

Gluten-Answers.com was founded in 2008 and is dedicated to educating the world on Celiac disease and gluten sensitivity. The website is a subsidiary of IMD, LLC, an Orlando-based Internet publisher.

###


Contact Information
Sean Ambrose
Gluten-Answers.com
http://www.gluten-answers.com
407-312-2933

Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy